Sera Prognostics
NASDAQ: SERASalt Lake City, US · Delaware corporation · 7 known investors
Find your way into Sera Prognostics
220 people in our graph share verified history with the Sera Prognostics team — schools, employers, funds. One of them is your warm intro.
Chris Feeneyunlockedknows Andrew A. Sauter · together at Bank of America (overlapped)
knows the team · via Bank of America
knows the team · via Achieve Life Sciences
×8knows the team · via Claremont McKenna College
knows the team · via Weber State University
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.
Founders & leadership
DF
Douglas FisherExecutive
JM
Jay MoyesinChief Financial Officer2020–2023Jay Moyes is Executive Officer of Sera Prognostics, which develops diagnostic blood tests and data platforms for pregnancy risk assessment. He brings over three decades of management experience at industry-leading companies during their growth and transition to public markets.
GC
Gregory C. CritchfieldinMember Board of Directors
AA
Andrew A. SauterinCFO2010–2020Andrew A. Sauter is Chief Executive Officer of Sera Prognostics, a women's health diagnostics company. He previously held finance and strategic leadership roles at venture-backed and public life science companies, including experience in clinical development, financing, reimbursement strategy, and M&A.
ZL
Zhenya LindgardtinCEO and PresidentZhenya Lindgardt previously held leadership roles at the Commons Project Foundation as CEO and at Uber as VP of Platform and Customer Engagement, and was a Senior Partner and Managing Director at Boston Consulting Group in New York. He holds a BA in Business Administration from the University of Southern California and an MBA from Harvard Business School.
Board
MM
Mansoor MirzaBoard director
RM
Ryan M. TrimbleBoard director
JS
DB
KK
MM
Michael MinahanBoard director
JP
Investors · 7
aMoonRa'anana
Excelestar VenturesAndover
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
UpStart VenturesSalt Lake Cityvia Dennis Farrar · board
Vivo CapitalPalo Alto · $10M – $50Mvia Joseph Siletto · board
Catalyst Health VenturesreportedBoston · $1M – $3M
Domain Associatesreported · 2 sourcesPrinceton · $200K – $15M
Reported raises · per SEC filings
Form D private placements$207.4M disclosed across 8 rounds · 2013–2021
▶$100.3MraisedMay 2021 · 16 investors · Other Health CareRule 506(b)
▶$100.3MraisedMay 2021 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mansoor MirzaDirector
- Marcus WilsonDirector
- Ryan M. TrimbleDirector
- Joseph SilettoDirector
- Dennis B. FarrarDirector
- Douglas FisherExecutive Officer
- Kim KamdarDirector
- Michael MinahanDirector
- Jay MoyesExecutive Officer
- Joshua PhillipsDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Elizabeth CanisDirector
- Charles KennedyDirector
- Offering amount
- $100.3M
- Amount sold
- $100.3M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$51.8MraisedFeb 2020 · 28 investors · Other Health CareRule 506(b)
▶$51.8MraisedFeb 2020 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas FisherExecutive Officer
- Dennis B. FarrarDirector
- Andrew A. SauterExecutive Officer
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Michael MinahanDirector
- Ryan M. TrimbleDirector
- Mansoor Raza MirzaDirector
- Charles D. KennedyDirector
- Arnold Oronsky, Ph.D.Director
- Kim KamdarDirector
- Offering amount
- $53.5M
- Amount sold
- $51.8M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedMar 2019 · 1 investors · Other Health CareRule 506(b)
▶$6.4MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis B. FarrarDirector
- Ryan M. TrimbleDirector
- Joshua PhillipsDirector
- Mansoor Raza MirzaDirector
- Douglas FisherExecutive Officer
- Arnold Oronsky, Ph.D.Director
- Andrew A. SauterExecutive Officer
- Michael MinahanDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Kim KamdarDirector
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.6MraisedDec 2018 · 12 investors · Other Health CareRule 506(b)
▶$7.6MraisedDec 2018 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arnold Oronsky, Ph.D.Director
- Michael MinahanDirector
- Douglas FisherExecutive Officer
- Joshua PhillipsDirector
- Mansoor Raza MirzaDirector
- Dennis B. FarrarDirector
- Andrew A. SauterExecutive Officer
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $7.6M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.7MraisedJan 2017 · 5 investors · Other Health CareRule 506(b)
▶$22.7MraisedJan 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Michael MinahanDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Douglas FisherExecutive Officer
- Andrew A. SauterExecutive Officer
- Dennis B. FarrarDirector
- Arnold Oronsky, Ph.D.Director
- Mansoor Raza MirzaDirector
- Offering amount
- $45M
- Amount sold
- $22.7M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2014 · 15 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2014 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis B. FarrarDirector
- Douglas FisherDirector
- Ryan M. TrimbleDirector
- Andrew A. SauterExecutive Officer
- Joshua PhillipsDirector
- Kim KamdarDirector
- Richard L. NovakDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.2MraisedJun 2014 · 15 investors · Other Health CareRule 506(b)
▶$9.2MraisedJun 2014 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas FisherDirector
- Kim KamdarDirector
- Richard L. NovakDirector
- Andrew A. SauterExecutive Officer
- Dennis B. FarrarDirector
- Ryan M. TrimbleDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Joshua PhillipsDirector
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedMar 2014 · 11 investors · Other Health CareRule 506(b)
▶$4.5MraisedMar 2014 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew A. SauterExecutive Officer
- Douglas FisherDirector
- Richard L. NovakDirector
- Joshua PhillipsDirector
- Gregory C. CritchfieldExecutive Officer, Director
- Ryan M. TrimbleDirector
- Kim KamdarDirector
- Dennis B. FarrarDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$488.1Mvaluation at IPOJul 2021 · $16.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 5
by search overlap
Seeking Alpha10 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Public9 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
StockTwits7 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Robinhood7 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView6 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Sera Prognostics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICERprnewswire.com · Aug 2026
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTStucson.com · Aug 2026Frequently asked questions
- What does Sera Prognostics do?
- Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.
- Who are Sera Prognostics's investors?
- Sera Prognostics's investors include aMoon, Excelestar Ventures, OUP (Osage University Partners), UpStart Ventures, Vivo Capital, Catalyst Health Ventures, Domain Associates.
- How much funding has Sera Prognostics raised?
- Sera Prognostics has disclosed $207.4M raised across 8 rounds.
- Where is Sera Prognostics headquartered?
- Sera Prognostics is headquartered in Salt Lake City, US.